Regorafenib for patients with metastatic colorectal cancer who progressed after standard therapy: results of the large, single‐arm, open‐label phase IIIb CONSIGN study
by Van Cutsem, Eric (Author)
, Martinelli, Erika (Author)
, Cascinu, Stefano (Author)
, Sobrero, Alberto (Author)
, Banzi, Maria (Author)
, Seitz, Jean‐François (Author)
, Barone, Carlo (Author)
, Ychou, Marc (Author)
, Peeters, Marc (Author)
, Brenner, Baruch (Author)
, Hofheinz, Ralf-Dieter (Author)
, Maiello, Evaristo (Author)
, André, Thierry (Author)
, Spallanzani, Andrea (Author)
, Garcia‐Carbonero, Rocio (Author)
, Arriaga, Yull E. (Author)
, Verma, Udit (Author)
, Grothey, Axel (Author)
, Kappeler, Christian (Author)
, Miriyala, Ashok (Author)
, Kalmus, Joachim (Author)
, Falcone, Alfredo (Author)
, Zaniboni, Alberto (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource